• Vol. 26 No. 5, 604–608
  • 01 September 1997

Increasing Antimicrobial Resistance in Clinical Isolates of Streptococcus pneumoniae

,

The presence of antibiotic-resistant Streptococcus pneumoniae has become a major clinical problem in several parts of the world. However, there is a lack of data from Southeast Asia. We therefore initiated a study to determine the serogroups/serotypes and antimicrobial susceptibilities of clinical strains of S. pneumoniae isolated in our laboratory.

In 1995, we isolated 144 strains of S. pneumoniae. Thirty-six (25.0%) strains were resistant to penicillin, of which 19 (13.2%) were highly resistant (minimal inhibitory concentration >1.0 µg/mL). Thirty-eight (26.4%) strains were resistant to erythromycin, 75 (52.1%) were resistant to tetracycline, 48 (33.3%) were resistant to sulfamethoxazole-trimethoprim, and 29 (20.1%) were resistant to chloramphenicol. Twenty of the penicillin-resistant strains also had diminished susceptibility to ceftriaxone. Strains resistant to penicillin belonged to serogroups/serotypes 6 (n = 1), 9 (n = 1), 23 (n = 4), 14 (n = 6), and 19 (n = 20). Children under 5 years of age were more likely than older children and adults to have isolates resistant to penicillin (52.9% versus 16.2%, P = 0.00002). Penicillin-resistant strains were more likely than penicillin-susceptible strains to be multidrug-resistant (86.1% versus 7.4%, P < 0.000005). We concluded that there is a high prevalence of penicillin-resistant pneumococci in our isolates, especially among very young children. Most penicillin-resistant strains belong to serogroup 19 and are also resistant to multiple drugs.

This article is available only as a PDF. Please click on “Download PDF” on top to view the full article.

Declaration

The author(s) declare there are no affiliations with or involvement in any organisation or entity with any financial interest in the subject matter or materials discussed in this manuscript.